研究者詳細 - 畠山　真吾

論文 - 畠山　真吾

分割表示470 件中 41 - 60 件目／全件表示 >>

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

PloS one 18 ( 2 ) e0275921 2023年

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Cancers 14 ( 24 ) 2022年12月

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology 2022年12月

Testicular teratomagenesis from primordial germ cells with overexpression of germinal center-associated nuclear protein.

Sakai Y, Yoshinaga K, Yoshida A, Rezano A, Shiogama K, Kawashima Y, Yoshizawa T, Yoshizawa A, Hatakeyama S, Ohyama C, Ito H, Abe M, Kijima H, Otsuki Y, Ito A, Tsuzuki T, Takeya M, Sakaguchi N, Kuwahara K

Cancer science 2022年12月

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

Takahashi S, Narita S, Fujiyama N, Hatakeyama S, Kobayashi T, Kato R, Naito S, Sakatani T, Kashima S, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Obara W, Tsuchiya N, Ohyama C, Ogawa O, Habuchi T

Cancer science 113 ( 12 ) 4059 - 4069 2022年12月

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male 25 ( 1 ) 1 - 7 2022年12月

Association of oxidative stress with erectile dysfunction in community-dwelling men and men on dialysis.

Fujita N, Momota M, Ishida M, Iwane T, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Yamaya K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male 25 ( 1 ) 193 - 201 2022年12月

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.

Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Andrology 10 ( 8 ) 1548 - 1555 2022年11月

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.

Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology 40 ( 10 ) 451.e1 - 451.e8 2022年10月

Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer.

Yanagisawa T, Kimura T, Hata K, Narita S, Hatakeyama S, Enei Y, Atsuta M, Mori K, Obayashi K, Yoshihara K, Kondo Y, Oguchi T, Sadakane I, Habuchi T, Ohyama C, Shariat SF, Egawa S

The Prostate 82 ( 14 ) 1322 - 1330 2022年10月

Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.

Narita S, Terada N, Nomura K, Sakamoto S, Hatakeyama S, Kato T, Matsui Y, Inokuchi J, Yokomizo A, Tabata KI, Shiota M, Kimura T, Kojima T, Inoue T, Mizowaki T, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H, Habuchi T, Japanese Urological Oncology Group

International journal of urology : official journal of the Japanese Urological Association 29 ( 10 ) 1147 - 1154 2022年10月

Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy.

Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 10 ) 1235 - 1237 2022年10月

尿路上皮癌・腎癌患者におけるSARSCoV-2ワクチンの血清反応に対する薬物療法の影響

富樫赳, 畠山真吾, 米山徹, 濱谷智子, 成田拓磨, 藤田尚紀, 岩村大径, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会抄録集 60回 P87 - 5 2022年10月

転移性腎癌におけるイピリムマブ・ニボルマブ併用療法の早期の耐性化と関連因子の検討

武藤弓奈, 沼倉一幸, 畠山真吾, 関根悠哉, 小林瑞貴, 嘉島相輝, 山本竜平, 奈良健平, 齋藤満, 成田伸太郎, 大山力, 羽渕友則

日本癌治療学会学術集会抄録集 60回 P51 - 1 2022年10月

Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Miura Y, Hatakeyama S, Narita S, Kimura T, Hata K, Yanagisawa T, Tanaka T, Ishi N, Kawamura S, Hoshi S, Ishidoya S, Mitsuzuka K, Ito A, Tsuchiya N, Egawa S, Habuchi T, Ohyama C

The Prostate 82 ( 13 ) 1304 - 1312 2022年09月

Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.

Narita S, Kimura T, Hatakeyama S, Hata K, Yanagisawa T, Maita S, Chiba S, Sato H, Kashima S, Koizumi A, Yamamoto R, Takayama K, Okane K, Ishida T, Horikawa Y, Kumazawa T, Shimoda J, Suzuki T, Ohyama C, Egawa S, Habuchi T

International journal of clinical oncology 27 ( 9 ) 1477 - 1486 2022年09月

Predicting perioperative outcomes of robot-assisted radical cystectomy: Data from the Asian Robot-Assisted Radical Cystectomy Consortium.

Lee AY, Allen JC Jr, Teoh JY, Kang SH, Patel MI, Muto S, Yang CK, Hatakeyama S, Zhang R, Kijvikai K, Chen H, Ohyama C, Horie S, Chan ES, Lee LS

International journal of urology : official journal of the Japanese Urological Association 29 ( 9 ) 1002 - 1009 2022年09月

周術期に血小板減少症を生じた腎移植ドナーの一例

小玉寛健, 岡本哲平, 山本勇人, 藤田雄, 村上礼一, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 35 ( 9 ) 1024 - 1024 2022年09月

診断に苦慮した右腎腫瘍の1例

小西栄, 岩村大径, 尾崎佑輔, 沖田和貴, 小玉寛健, 成田拓磨, 小島由太, 藤田尚紀, 岡本哲平, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 35 ( 9 ) 1022 - 1022 2022年09月

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Scientific reports 12 ( 1 ) 13786 2022年08月

　前のページ - 次のページ　

<畠山 真吾>

論文 - 畠山 真吾

<畠山　真吾>

論文 - 畠山　真吾